Safety and Feasibility of PD-1 Blockade in the Treatment of dMMR or MSI-H Rectal Cancer

NCT04357587 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Rectal Neoplasms

Interventions

DRUG: Pembrolizumab
RADIATION: External beam radiation
DRUG: Capecitabine

Sponsor

Case Comprehensive Cancer Center